Jon Tester: “Do you think more transparency would make medications more profitable for the patient or less?”

Thank you, Mr. Chairman. I appreciate the flexibility.

That's between me and the ballot box.

It is always good to have you in front of the Committee.

This has been a rubber stamp Congress so far.